Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zylox-Tonbridge Medical Technology Co Ltd
Total Current Liabilities
Zylox-Tonbridge Medical Technology Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
Total Current Liabilities
¥152.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Current Liabilities
¥406m
|
CAGR 3-Years
28%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Current Liabilities
¥2.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
16%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Current Liabilities
¥11.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Total Current Liabilities
¥3.2B
|
CAGR 3-Years
27%
|
CAGR 5-Years
51%
|
CAGR 10-Years
33%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Current Liabilities
¥7.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Zylox-Tonbridge Medical Technology Co Ltd
Glance View
Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.
See Also
What is Zylox-Tonbridge Medical Technology Co Ltd's Total Current Liabilities?
Total Current Liabilities
152.1m
CNY
Based on the financial report for Dec 31, 2024, Zylox-Tonbridge Medical Technology Co Ltd's Total Current Liabilities amounts to 152.1m CNY.
What is Zylox-Tonbridge Medical Technology Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
35%
Over the last year, the Total Current Liabilities growth was 0%. The average annual Total Current Liabilities growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been 16% over the past three years , 35% over the past five years .
